연구

임상연구지원 (CIDR)

임상연구지원 (CIDR)

심장혈관질환 분야의 연구 의욕을 고취시키기 위해, 새로운 치료법을 모색하는 연구계획서를 제출한 연구자들을 선정하여 각종 지원을 하고 있습니다.

Research Activity

  • Intravascular Ultrasound Study to Evaluate Cardiac Allograft Vasculopathy in Heart Transplant Recipients
  • Evaluation of Effectiveness and Safety of XIENCE Sierra in Routine Clinical Practice; A Multicenter, Prospective Observational Study
  • Anticoagulant versus Dual Antiplatelet Therapy for Preventing Leaflet Thrombosis and Cerebral Embolization After Transcatheter Aortic Valve Replacement
  • Asan Medical Center Myocardial Infarction registry (AMC-MI registry)
  • Perioperative antiplatelet therapy in patients with drug-eluting stent undergoing noncardiac surgery
  • BVS Implantation in Patients with Variant Angina and MODerate coronary artery disease: Pilot study
  • IRIS CTO; a multicenter, prospective, real world observational study for Chronic Total Occlusion
  • An open-label, randomized, controlled, multicenter study comparing two treatment strategies of Edoxaban alone and Edoxaban with antiplatelet agent in patients with atrial fibrillation and chronic stable coronary artery disease
  • Early Left Atrial Venting Versus Conventional Treatment For Left VEntricular Decompression During Venoarterial ExtraCorporeal Membrane Oxygenation Support
  • Evaluation of Effectiveness and Safety of Hybrid Coronary Revascularization
  • Evaluation of Effectiveness and Safety of Aortic Valve Replacement in Routine Clinical Practice; A Multicenter, Prospective Observational Study
  • Evaluation of Effectiveness and Safety of BioFreedom stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
  • Evaluation of Effectiveness and Safety of Bioresorbable Vascular Scaffold in Routine Clinical Practice ; A Multicenter, Prospective Observational Study
  • Evaluation of effectiveness and safety of Drug-Eluting Balloon in Routine Clinical Practice; A multicenter prospective observational cohort study (IRIS-DEB)
  • Evaluation of Effectiveness and Safety of DESyne X2R in Routine Clinical Practice; A Multicenter, Prospective Observational Study
  • A Multicenter, prospective cohort to evaluate the natural history of FFR guided Percutaneous Coronary Intervention (IRIS FFR Registry)
  • A Multicenter, prospective cohort to evaluate the effect of FFR guided Percutaneous Coronary Intervention in coronary tandem lesions (IRIS FFR Tandem Registry)
  • Prognosis of Coronary Stenosis based on Intracoronary Imaging; A Multicenter, Prospective Observational Study
  • Prognosis of Coronary Stenosis based on Grayscale Intravascular Ultrasound; A Multicenter, Prospective Observational Study
  • IRIS MAIN ; a global, multicenter, prospective, real world observational study for left main disease treatment
  • Evaluation of Effectiveness and Safety of Resolute Onyx in Routine Clinical Practice; A Multicenter, Prospective Observational Study
  • Evaluation of Effectiveness and Safety of Rotational Atherectomy in Routine Clinical Practice; A Multicenter, Prospective Observational Study
  • Evaluation of Effectiveness and Safety of Synergy Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
  • Evaluation of Effectiveness and Safety of XIENCE XPEDITION in Routine Clinical Practice; A Multicenter, Prospective Observational Study
  • Optical Coherence Tomography versus IntraVascular UltraSound Guided Percutaneous Coronary Intervention Trial
  • IRIS MAIN ; a global, multicenter, prospective, real world observational study for left main disease treatment
  • Ten-Year Outcomes of PREmier of Randomized Comparison of Sirolimus-Eluting Stent Implantation Versus Coronary Artery Bypass Surgery for Unprotected Left Main Coronary Artery Stenosis: PRE-COMBAT Trial
  • The Preventive Coronary Intervention on Stenosis With Functionally Insignificant Vulnerable Plaque
  • Prognosis of Coronary Stenosis based on Intracoronary Imaging; A Multicenter, Prospective Observational Study
  • Debulking with Rotational atherectomy versus Balloon Angioplasty In Patients with In-stent Restenosis
  • Comparison of Tailored Antiplatelet Therapy With Early Intensified and Late Deescalated Strategy versus Standard Dual Antiplatelet Therapy in Patients Undergoing High-Risk Complex Percutaneous Coronary Intervention
  • TransPacific TAVR Registry(Multinational Multicenter Prospective Registry)
  • Implantable Cardioverter Defibrillator versus Optimal Medical Therapy In Patients with Variant Angina Manifesting as Aborted Sudden Cardiac Death (VARIANT-ICD trial)
  • The BEST TRIAL Randomized Comparison of Coronary Artery Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients with Multivessel Coronary Artery Disease: Phase IV: Multicenter
  • Optimal Duration of Clopidogrel Therapy after Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events (BVS-LATE trial)
  • Optimal Duration of Clopidogrel Therapy after Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events (BVS-LATE trial)
  • A Randomized, Double-blind Study of Effect of Fimasartan for Modification of Atheroma Vulnerability in Deferred Coronary Disease
  • HOW To Optimally Implant BioResorbable Scaffold - Intravascular Imaging versus Quantitative Coronary Angiography guidance: HOWTO-BRS trial
  • Evaluation of Effectiveness and Safety of BIOMATRIX in Routine Clinical Practice A multicenter, PROSPECTIVE OBSERVATIONAL STUDY
  • Evaluation of Effectiveness and Safety of DESyne in Routine Clinical Practice ; A Multicenter, Prospective Observational Study
  • Evaluation of Effectiveness and Safety of PROMUS Element in Routine Clinical Practice; A multicenter, PROSPECTIVE OBSERVATIONAL STUDY
  • Evaluation of effectiveness and safety of Resolute Integrity DES in Routine Clinical Practice; A multicenter prospective observational cohort study
  • Evaluation of Effectiveness and Safety of NOBORI stent in Routine Clinical Practice;A multicenter, PROSPECTIVE OBSERVATIONAL STUDY
  • Evaluation of Effectiveness and Safety of Orsiro in Routine Clinical Practice; A Multicenter, Prospective Observational Study
  • Evaluation of Effectiveness and Safety of Promus PREMIER in Routine Clinical Practice; A Multicenter, Phase-IV, Prospective Observational Study
  • Evaluation of Effectiveness and Safety of XIENCE PRIME in Routine Clinical Practice; A MULTICENTER, PROSPECTIVE OBSERVATIONAL STUDY
  • Evaluation of Effectiveness and Safety of Ultimaster stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
  • Percutaneous Treatment of LONG Native Coronary Lesions with Drug-Eluting Stent-VI: Everolimus-eluting (Xience-Prime) vs. Zotarolimus-Eluting (Resolute-Integrity) Stents
  • Percutaneous Treatment of LONG Native Coronary Lesions with Drug-Eluting Stent-VII: Sirolimus-eluting (Ultimaster) vs. Everolimus-Eluting Stents (Xience)
  • Ten-Year Outcomes of Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease
  • Device Closure versus Medical Therapy for Secondary Prevention in Cryptogenic Stroke Patients with High-Risk Patent Foramen Ovale : DEFENSE-PFO trial
  • Pragmatic Trial Comparing Symptom-Oriented Versus Routine Stress Testing in High-Risk Patients Undergoing Percutaneous Coronary Intervention: POST-PCI trial
  • Effectiveness of Clopidogrel Resinate(PRegrel? in Patients Undergoing Percutaneous Coronary Intervention compared with ClopiDogrEl Bisulfate(Plavix?
  • Transcatheter Aortic Valve Replacement for Pure Severe Aortic Regurgitation Pilot study
  • Treatment of Drug-Eluting Stent REstenosis Using Drug-Eluting STents vs. Drug-COated Balloon for Preventing REcurrent In-Stent Restenosis
  • Comparison of Low-Dose, Standard-Dose Ticagrelor and Clopidogrel for Inhibition of Platelet Reactivity in Patients with Acute Coronary Syndromes; Pharmacodynamics and Pharmacokinetics Study (The OPTIMA Trial)
  • A randomized, open-label, parallel group, multicenter phase IV study to assess safety and efficacy of Ticagrelor versus Clopidogrel in Asian/KOREAn patients with acute coronary syndromes intended for invasive management: TICAKOREA Trial